| abstract |
The present invention relates to viral Fc receptors or immunogenic fragments thereof for use in the treatment of viral infections, in particular herpes virus infections, in a subject. The present invention also relates to a heterodimer for use in therapy comprising or consisting of an Fc receptor or an immunogenic fragment thereof from an HSV virus and a binding partner or a fragment thereof from said HSV virus. |